Industry Research Reports

Home > Reports > Pharma & Healthcare > Global and China Recombinant Coagulation Factor Concentrate Market Report & Forecast 2024-2030

Global and China Recombinant Coagulation Factor Concentrate Market Report & Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-11-19

Pages: 148 Pages

Report ld: 3382157

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Recombinant Coagulation Factor Concentrate revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In China the Recombinant Coagulation Factor Concentrate revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and China Recombinant Coagulation Factor Concentrate market, also covers the segmentation data of other regions in regional level and county level.

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines. Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Recombinant Coagulation Factor Concentrate market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Recombinant Coagulation Factor Concentrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For China market, this report focuses on the Recombinant Coagulation Factor Concentrate market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in China.

Market Segmentation

Report Metric
Details
Report Title
Global and China Recombinant Coagulation Factor Concentrate Market Report & Forecast 2024-2030
Global Recombinant Coagulation Factor Concentrate Companies Covered
Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL, Baxalta, Sanofi, Biogen, Pfizer, Novo Disk, Baxter, Wyeth, Beijing Tiantan Biological Products, SHANGHAI RAAS, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, Green Cross
Global Recombinant Coagulation Factor Concentrate Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Coagulation Factor Concentrate Market, Segment by Type
250 IU

500 IU

1000 IU

2000 IU
Global Recombinant Coagulation Factor Concentrate Market, Segment by Application
Hopistial

Clinic

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces Recombinant Coagulation Factor Concentrate definition, global sales (volume and revenue), China market size, China percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Recombinant Coagulation Factor Concentrate companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Recombinant Coagulation Factor Concentrate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Coagulation Factor Concentrate sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

Table of Contents

 1 Study Coverage
    1.1 Recombinant Coagulation Factor Concentrate Product Introduction
    1.2 Global Recombinant Coagulation Factor Concentrate Outlook 2019 VS 2023 VS 2030
        1.2.1 Global Recombinant Coagulation Factor Concentrate Sales in US$ Million for the Year 2019-2030
        1.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume for the Year 2019-2030
    1.3 China Recombinant Coagulation Factor Concentrate Outlook 2019 VS 2023 VS 2030
        1.3.1 China Recombinant Coagulation Factor Concentrate Sales in US$ Million for the Year 2019-2030
        1.3.2 China Recombinant Coagulation Factor Concentrate Sales in Volume for the Year 2019-2030
    1.4 Recombinant Coagulation Factor Concentrate Market Size, China VS Global, 2019 VS 2023 VS 2030
        1.4.1 The Market Share of China Recombinant Coagulation Factor Concentrate in Global, 2019 VS 2023 VS 2030
        1.4.2 The Growth Rate of Recombinant Coagulation Factor Concentrate Market Size, China VS Global, 2019 VS 2023 VS 2030
    1.5 Recombinant Coagulation Factor Concentrate Market Dynamics
        1.5.1 Recombinant Coagulation Factor Concentrate Industry Trends
        1.5.2 Recombinant Coagulation Factor Concentrate Market Drivers
        1.5.3 Recombinant Coagulation Factor Concentrate Market Challenges
        1.5.4 Recombinant Coagulation Factor Concentrate Market Restraints
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

 2 Recombinant Coagulation Factor Concentrate by Type
    2.1 Recombinant Coagulation Factor Concentrate Market by Type
        2.1.1 250 IU
        2.1.2 500 IU
        2.1.3 1000 IU
        2.1.4 2000 IU
    2.2 Global Recombinant Coagulation Factor Concentrate Market Size by Type
        2.2.1 Global Recombinant Coagulation Factor Concentrate Sales in Value, by Type (2019, 2023 & 2030)
        2.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume, by Type (2019, 2023 & 2030)
        2.2.3 Global Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Type (2019, 2023 & 2030)
    2.3 China Recombinant Coagulation Factor Concentrate Market Size by Type
        2.3.1 China Recombinant Coagulation Factor Concentrate Sales in Value, by Type (2019, 2023 & 2030)
        2.3.2 China Recombinant Coagulation Factor Concentrate Sales in Volume, by Type (2019, 2023 & 2030)
        2.3.3 China Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Type (2019, 2023 & 2030)

 3 Recombinant Coagulation Factor Concentrate by Application
    3.1 Recombinant Coagulation Factor Concentrate Market by Application
        3.1.1 Hopistial
        3.1.2 Clinic
        3.1.3 Others
    3.2 Global Recombinant Coagulation Factor Concentrate Market Size by Application
        3.2.1 Global Recombinant Coagulation Factor Concentrate Sales in Value, by Application (2019, 2023 & 2030)
        3.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2019, 2023 & 2030)
        3.2.3 Global Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Application (2019, 2023 & 2030)
    3.3 China Recombinant Coagulation Factor Concentrate Market Size by Application
        3.3.1 China Recombinant Coagulation Factor Concentrate Sales in Value, by Application (2019, 2023 & 2030)
        3.3.2 China Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2019, 2023 & 2030)
        3.3.3 China Recombinant Coagulation Factor Concentrate Average Selling Price (ASP) by Application (2019, 2023 & 2030)

 4 Global Recombinant Coagulation Factor Concentrate Competitor Landscape by Company
    4.1 Global Recombinant Coagulation Factor Concentrate Market Size by Company
        4.1.1 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Ranked by Revenue (2023)
        4.1.2 Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturer (2019-2024)
        4.1.3 Global Recombinant Coagulation Factor Concentrate Sales by Manufacturer (2019-2024)
        4.1.4 Global Recombinant Coagulation Factor Concentrate Price by Manufacturer (2019-2024)
    4.2 Global Recombinant Coagulation Factor Concentrate Concentration Ratio (CR)
        4.2.1 Recombinant Coagulation Factor Concentrate Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Coagulation Factor Concentrate in 2023
        4.2.3 Global Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Product Offered and Application
    4.5 Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 China Recombinant Coagulation Factor Concentrate Market Size by Company
        4.7.1 Key Players of Recombinant Coagulation Factor Concentrate in China, Ranked by Revenue (2023)
        4.7.2 China Recombinant Coagulation Factor Concentrate Revenue by Players (2019-2024)
        4.7.3 China Recombinant Coagulation Factor Concentrate Sales by Players (2019-2024)

 5 Global Recombinant Coagulation Factor Concentrate Market Size by Region
    5.1 Global Recombinant Coagulation Factor Concentrate Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global Recombinant Coagulation Factor Concentrate Market Size in Volume by Region (2019-2030)
        5.2.1 Global Recombinant Coagulation Factor Concentrate Sales in Volume by Region: 2019-2024
        5.2.2 Global Recombinant Coagulation Factor Concentrate Sales in Volume Forecast by Region (2025-2030)
    5.3 Global Recombinant Coagulation Factor Concentrate Market Size in Value by Region (2019-2030)
        5.3.1 Global Recombinant Coagulation Factor Concentrate Sales in Value by Region: 2019-2024
        5.3.2 Global Recombinant Coagulation Factor Concentrate Sales in Value by Region: 2025-2030

 6 Americas
    6.1 Americas Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2019-2030
    6.2 Americas Recombinant Coagulation Factor Concentrate Sales in Volume, by Type (2019, 2023 & 2030)
    6.3 Americas Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2019, 2023 & 2030)
    6.4 Americas Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 Americas Recombinant Coagulation Factor Concentrate Sales in Value by Country (2019, 2023 & 2030)
        6.4.2 Americas Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2019, 2023 & 2030)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil

 7 EMEA
    7.1 EMEA Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2019-2030
    7.2 EMEA Recombinant Coagulation Factor Concentrate Sales in Volume, by Type (2019, 2023 & 2030)
    7.3 EMEA Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2019, 2023 & 2030)
    7.4 EMEA Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country (2019, 2023 & 2030)
        7.4.1 EMEA Recombinant Coagulation Factor Concentrate Sales in Value by Country (2019, 2023 & 2030)
        7.4.2 EMEA Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2019, 2023 & 2030)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa

 8 China
    8.1 China Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2019-2030
    8.2 China Recombinant Coagulation Factor Concentrate Sales in Volume, by Type (2019, 2023 & 2030)
    8.3 China Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2019, 2023 & 2030)

 9 APAC
    9.1 APAC Recombinant Coagulation Factor Concentrate Market Size YoY Growth 2019-2030
    9.2 APAC Recombinant Coagulation Factor Concentrate Sales in Volume, by Type (2019, 2023 & 2030)
    9.3 APAC Recombinant Coagulation Factor Concentrate Sales in Volume, by Application (2019, 2023 & 2030)
    9.4 APAC Recombinant Coagulation Factor Concentrate Market Facts & Figures by Country (2019, 2023 & 2030)
        9.4.1 APAC Recombinant Coagulation Factor Concentrate Sales in Value by Country (2019, 2023 & 2030)
        9.4.2 APAC Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2019, 2023 & 2030)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India

 10 Company Profiles
    10.1 Bayer
        10.1.1 Bayer Company Information
        10.1.2 Bayer Description and Business Overview
        10.1.3 Bayer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.1.4 Bayer Recombinant Coagulation Factor Concentrate Products Offered
        10.1.5 Bayer Recent Development
    10.2 Alprolix
        10.2.1 Alprolix Company Information
        10.2.2 Alprolix Description and Business Overview
        10.2.3 Alprolix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.2.4 Alprolix Recombinant Coagulation Factor Concentrate Products Offered
        10.2.5 Alprolix Recent Development
    10.3 Benefix
        10.3.1 Benefix Company Information
        10.3.2 Benefix Description and Business Overview
        10.3.3 Benefix Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.3.4 Benefix Recombinant Coagulation Factor Concentrate Products Offered
        10.3.5 Benefix Recent Development
    10.4 Idelvion
        10.4.1 Idelvion Company Information
        10.4.2 Idelvion Description and Business Overview
        10.4.3 Idelvion Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.4.4 Idelvion Recombinant Coagulation Factor Concentrate Products Offered
        10.4.5 Idelvion Recent Development
    10.5 Lxinity
        10.5.1 Lxinity Company Information
        10.5.2 Lxinity Description and Business Overview
        10.5.3 Lxinity Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.5.4 Lxinity Recombinant Coagulation Factor Concentrate Products Offered
        10.5.5 Lxinity Recent Development
    10.6 Rebinyn
        10.6.1 Rebinyn Company Information
        10.6.2 Rebinyn Description and Business Overview
        10.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Products Offered
        10.6.5 Rebinyn Recent Development
    10.7 Rixubis
        10.7.1 Rixubis Company Information
        10.7.2 Rixubis Description and Business Overview
        10.7.3 Rixubis Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.7.4 Rixubis Recombinant Coagulation Factor Concentrate Products Offered
        10.7.5 Rixubis Recent Development
    10.8 CSL
        10.8.1 CSL Company Information
        10.8.2 CSL Description and Business Overview
        10.8.3 CSL Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.8.4 CSL Recombinant Coagulation Factor Concentrate Products Offered
        10.8.5 CSL Recent Development
    10.9 Baxalta
        10.9.1 Baxalta Company Information
        10.9.2 Baxalta Description and Business Overview
        10.9.3 Baxalta Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.9.4 Baxalta Recombinant Coagulation Factor Concentrate Products Offered
        10.9.5 Baxalta Recent Development
    10.10 Sanofi
        10.10.1 Sanofi Company Information
        10.10.2 Sanofi Description and Business Overview
        10.10.3 Sanofi Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.10.4 Sanofi Recombinant Coagulation Factor Concentrate Products Offered
        10.10.5 Sanofi Recent Development
    10.11 Biogen
        10.11.1 Biogen Company Information
        10.11.2 Biogen Description and Business Overview
        10.11.3 Biogen Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.11.4 Biogen Recombinant Coagulation Factor Concentrate Products Offered
        10.11.5 Biogen Recent Development
    10.12 Pfizer
        10.12.1 Pfizer Company Information
        10.12.2 Pfizer Description and Business Overview
        10.12.3 Pfizer Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.12.4 Pfizer Recombinant Coagulation Factor Concentrate Products Offered
        10.12.5 Pfizer Recent Development
    10.13 Novo Disk
        10.13.1 Novo Disk Company Information
        10.13.2 Novo Disk Description and Business Overview
        10.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Products Offered
        10.13.5 Novo Disk Recent Development
    10.14 Baxter
        10.14.1 Baxter Company Information
        10.14.2 Baxter Description and Business Overview
        10.14.3 Baxter Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.14.4 Baxter Recombinant Coagulation Factor Concentrate Products Offered
        10.14.5 Baxter Recent Development
    10.15 Wyeth
        10.15.1 Wyeth Company Information
        10.15.2 Wyeth Description and Business Overview
        10.15.3 Wyeth Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.15.4 Wyeth Recombinant Coagulation Factor Concentrate Products Offered
        10.15.5 Wyeth Recent Development
    10.16 Beijing Tiantan Biological Products
        10.16.1 Beijing Tiantan Biological Products Company Information
        10.16.2 Beijing Tiantan Biological Products Description and Business Overview
        10.16.3 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.16.4 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Products Offered
        10.16.5 Beijing Tiantan Biological Products Recent Development
    10.17 SHANGHAI RAAS
        10.17.1 SHANGHAI RAAS Company Information
        10.17.2 SHANGHAI RAAS Description and Business Overview
        10.17.3 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.17.4 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Products Offered
        10.17.5 SHANGHAI RAAS Recent Development
    10.18 Taibang Biologic Group
        10.18.1 Taibang Biologic Group Company Information
        10.18.2 Taibang Biologic Group Description and Business Overview
        10.18.3 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.18.4 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Products Offered
        10.18.5 Taibang Biologic Group Recent Development
    10.19 HUALAN BIOLOGICAL ENGINEERING
        10.19.1 HUALAN BIOLOGICAL ENGINEERING Company Information
        10.19.2 HUALAN BIOLOGICAL ENGINEERING Description and Business Overview
        10.19.3 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.19.4 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Products Offered
        10.19.5 HUALAN BIOLOGICAL ENGINEERING Recent Development
    10.20 Green Cross
        10.20.1 Green Cross Company Information
        10.20.2 Green Cross Description and Business Overview
        10.20.3 Green Cross Recombinant Coagulation Factor Concentrate Sales, Revenue and Gross Margin (2019-2024)
        10.20.4 Green Cross Recombinant Coagulation Factor Concentrate Products Offered
        10.20.5 Green Cross Recent Development

 11 Industry Chain and Sales Channels Analysis
    11.1 Recombinant Coagulation Factor Concentrate Industry Chain Analysis
    11.2 Recombinant Coagulation Factor Concentrate Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 Recombinant Coagulation Factor Concentrate Production Mode & Process
    11.4 Recombinant Coagulation Factor Concentrate Sales and Marketing
        11.4.1 Recombinant Coagulation Factor Concentrate Sales Channels
        11.4.2 Recombinant Coagulation Factor Concentrate Distributors
    11.5 Recombinant Coagulation Factor Concentrate Customers

 12 Research Findings and Conclusion

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Recombinant Coagulation Factor Concentrate CAGR in Value, China VS Global, 2019 VS 2023 VS 2030
 Table 2. Recombinant Coagulation Factor Concentrate Market Trends
 Table 3. Recombinant Coagulation Factor Concentrate Market Drivers
 Table 4. Recombinant Coagulation Factor Concentrate Market Challenges
 Table 5. Recombinant Coagulation Factor Concentrate Market Restraints
 Table 6. Global Recombinant Coagulation Factor Concentrate Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. China Recombinant Coagulation Factor Concentrate Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Recombinant Coagulation Factor Concentrate Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. China Recombinant Coagulation Factor Concentrate Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global Recombinant Coagulation Factor Concentrate Revenue by Manufacturer, (US$ Million) & (2019-2024)
 Table 12. Global Recombinant Coagulation Factor Concentrate Revenue Share by Manufacturer, 2019-2024
 Table 13. Global Recombinant Coagulation Factor Concentrate Sales by Manufacturer, (K Units), 2019-2024
 Table 14. Global Recombinant Coagulation Factor Concentrate Sales Share by Manufacturer, 2019-2024
 Table 15. Global Recombinant Coagulation Factor Concentrate Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 16. Global Recombinant Coagulation Factor Concentrate Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global Recombinant Coagulation Factor Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Concentrate as of 2023)
 Table 18. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Manufacturing Base Distribution and Headquarters
 Table 19. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Product Offered and Application
 Table 20. Global Key Manufacturers of Recombinant Coagulation Factor Concentrate, Date of Enter into This Industry
 Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 22. Key Players of Recombinant Coagulation Factor Concentrate in China, Ranked by Revenue (2023) & (US$ million)
 Table 23. China Recombinant Coagulation Factor Concentrate Revenue by Players, (US$ Million) & (2019-2024)
 Table 24. China Recombinant Coagulation Factor Concentrate Revenue Share by Players, (2019-2024)
 Table 25. China Recombinant Coagulation Factor Concentrate Sales by Players, (K Units) & (2019-2024)
 Table 26. China Recombinant Coagulation Factor Concentrate Sales Share by Players, (2019-2024)
 Table 27. Global Recombinant Coagulation Factor Concentrate Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 28. Global Recombinant Coagulation Factor Concentrate Sales in Volume by Region (2019-2024) & (K Units)
 Table 29. Global Recombinant Coagulation Factor Concentrate Sales in Volume Forecast by Region (2025-2030) & (K Units)
 Table 30. Global Recombinant Coagulation Factor Concentrate Sales in Value by Region (2019-2024) & (US$ Million)
 Table 31. Global Recombinant Coagulation Factor Concentrate Sales in Value Forecast by Region (2025-2030) & (US$ Million)
 Table 32. Americas Recombinant Coagulation Factor Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. Americas Recombinant Coagulation Factor Concentrate Sales in Value by Country (2019-2024) & (US$ Million)
 Table 34. Americas Recombinant Coagulation Factor Concentrate Sales in Value by Country (2025-2030) & (US$ Million)
 Table 35. Americas Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2019-2024) & (K Units)
 Table 36. Americas Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2025-2030) & (K Units)
 Table 37. EMEA Recombinant Coagulation Factor Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. EMEA Recombinant Coagulation Factor Concentrate Sales in Value by Country (2019-2024) & (US$ Million)
 Table 39. EMEA Recombinant Coagulation Factor Concentrate Sales in Value by Country (2025-2030) & (US$ Million)
 Table 40. EMEA Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2019-2024) & (K Units)
 Table 41. EMEA Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2025-2030) & (K Units)
 Table 42. APAC Recombinant Coagulation Factor Concentrate Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. APAC Recombinant Coagulation Factor Concentrate Sales in Value by Country (2019-2024) & (US$ Million)
 Table 44. APAC Recombinant Coagulation Factor Concentrate Sales in Value by Country (2025-2030) & (US$ Million)
 Table 45. APAC Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2019-2024) & (K Units)
 Table 46. APAC Recombinant Coagulation Factor Concentrate Sales in Volume by Country (2025-2030) & (K Units)
 Table 47. Bayer Company Information
 Table 48. Bayer Description and Business Overview
 Table 49. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 50. Bayer Recombinant Coagulation Factor Concentrate Product
 Table 51. Bayer Recent Development
 Table 52. Alprolix Company Information
 Table 53. Alprolix Description and Business Overview
 Table 54. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 55. Alprolix Recombinant Coagulation Factor Concentrate Product
 Table 56. Alprolix Recent Development
 Table 57. Benefix Company Information
 Table 58. Benefix Description and Business Overview
 Table 59. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 60. Benefix Recombinant Coagulation Factor Concentrate Product
 Table 61. Benefix Recent Development
 Table 62. Idelvion Company Information
 Table 63. Idelvion Description and Business Overview
 Table 64. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 65. Idelvion Recombinant Coagulation Factor Concentrate Product
 Table 66. Idelvion Recent Development
 Table 67. Lxinity Company Information
 Table 68. Lxinity Description and Business Overview
 Table 69. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 70. Lxinity Recombinant Coagulation Factor Concentrate Product
 Table 71. Lxinity Recent Development
 Table 72. Rebinyn Company Information
 Table 73. Rebinyn Description and Business Overview
 Table 74. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 75. Rebinyn Recombinant Coagulation Factor Concentrate Product
 Table 76. Rebinyn Recent Development
 Table 77. Rixubis Company Information
 Table 78. Rixubis Description and Business Overview
 Table 79. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 80. Rixubis Recombinant Coagulation Factor Concentrate Product
 Table 81. Rixubis Recent Development
 Table 82. CSL Company Information
 Table 83. CSL Description and Business Overview
 Table 84. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 85. CSL Recombinant Coagulation Factor Concentrate Product
 Table 86. CSL Recent Development
 Table 87. Baxalta Company Information
 Table 88. Baxalta Description and Business Overview
 Table 89. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 90. Baxalta Recombinant Coagulation Factor Concentrate Product
 Table 91. Baxalta Recent Development
 Table 92. Sanofi Company Information
 Table 93. Sanofi Description and Business Overview
 Table 94. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 95. Sanofi Recombinant Coagulation Factor Concentrate Product
 Table 96. Sanofi Recent Development
 Table 97. Biogen Company Information
 Table 98. Biogen Description and Business Overview
 Table 99. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 100. Biogen Recombinant Coagulation Factor Concentrate Product
 Table 101. Biogen Recent Development
 Table 102. Pfizer Company Information
 Table 103. Pfizer Description and Business Overview
 Table 104. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 105. Pfizer Recombinant Coagulation Factor Concentrate Product
 Table 106. Pfizer Recent Development
 Table 107. Novo Disk Company Information
 Table 108. Novo Disk Description and Business Overview
 Table 109. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. Novo Disk Recombinant Coagulation Factor Concentrate Product
 Table 111. Novo Disk Recent Development
 Table 112. Baxter Company Information
 Table 113. Baxter Description and Business Overview
 Table 114. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Baxter Recombinant Coagulation Factor Concentrate Product
 Table 116. Baxter Recent Development
 Table 117. Wyeth Company Information
 Table 118. Wyeth Description and Business Overview
 Table 119. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Wyeth Recombinant Coagulation Factor Concentrate Product
 Table 121. Wyeth Recent Development
 Table 122. Beijing Tiantan Biological Products Company Information
 Table 123. Beijing Tiantan Biological Products Description and Business Overview
 Table 124. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 125. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product
 Table 126. Beijing Tiantan Biological Products Recent Development
 Table 127. SHANGHAI RAAS Company Information
 Table 128. SHANGHAI RAAS Description and Business Overview
 Table 129. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 130. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product
 Table 131. SHANGHAI RAAS Recent Development
 Table 132. Taibang Biologic Group Company Information
 Table 133. Taibang Biologic Group Description and Business Overview
 Table 134. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 135. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product
 Table 136. Taibang Biologic Group Recent Development
 Table 137. HUALAN BIOLOGICAL ENGINEERING Company Information
 Table 138. HUALAN BIOLOGICAL ENGINEERING Description and Business Overview
 Table 139. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 140. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product
 Table 141. HUALAN BIOLOGICAL ENGINEERING Recent Development
 Table 142. Green Cross Company Information
 Table 143. Green Cross Description and Business Overview
 Table 144. Green Cross Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 145. Green Cross Recombinant Coagulation Factor Concentrate Product
 Table 146. Green Cross Recent Development
 Table 147. Key Raw Materials Lists
 Table 148. Raw Materials Key Suppliers Lists
 Table 149. Recombinant Coagulation Factor Concentrate Distributors List
 Table 150. Recombinant Coagulation Factor Concentrate Customers List
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Coagulation Factor Concentrate Product Picture
 Figure 2. Global Recombinant Coagulation Factor Concentrate Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global Recombinant Coagulation Factor Concentrate Market Size 2019-2030 (US$ Million)
 Figure 4. Global Recombinant Coagulation Factor Concentrate Sales 2019-2030 (K Units)
 Figure 5. China Recombinant Coagulation Factor Concentrate Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 6. China Recombinant Coagulation Factor Concentrate Market Size 2019-2030 (US$ Million)
 Figure 7. China Recombinant Coagulation Factor Concentrate Sales 2019-2030 (K Units)
 Figure 8. China Recombinant Coagulation Factor Concentrate Market Share in Global, in Value (US$ Million) 2019-2030
 Figure 9. China Recombinant Coagulation Factor Concentrate Market Share in Global, in Volume (K Units) 2019-2030
 Figure 10. Recombinant Coagulation Factor Concentrate Report Years Considered
 Figure 11. Product Picture of 250 IU
 Figure 12. Product Picture of 500 IU
 Figure 13. Product Picture of 1000 IU
 Figure 14. Product Picture of 2000 IU
 Figure 15. Global Recombinant Coagulation Factor Concentrate Market Share by Type in 2023 & 2030
 Figure 16. Global Recombinant Coagulation Factor Concentrate Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 17. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Type (2019-2030)
 Figure 18. Global Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030) & (K Units)
 Figure 19. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2019-2030)
 Figure 20. Global Recombinant Coagulation Factor Concentrate Price by Type (2019-2030) & (US$/Unit)
 Figure 21. China Recombinant Coagulation Factor Concentrate Market Share by Type in 2023 & 2030
 Figure 22. China Recombinant Coagulation Factor Concentrate Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 23. China Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Type (2019-2030)
 Figure 24. China Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030) & (K Units)
 Figure 25. China Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2019-2030)
 Figure 26. China Recombinant Coagulation Factor Concentrate Price by Type (2019-2030) & (US$/Unit)
 Figure 27. Product Picture of Hopistial
 Figure 28. Product Picture of Clinic
 Figure 29. Product Picture of Others
 Figure 30. Global Recombinant Coagulation Factor Concentrate Market Share by Application in 2023 & 2030
 Figure 31. Global Recombinant Coagulation Factor Concentrate Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 32. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Application (2019-2030)
 Figure 33. Global Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030) & (K Units)
 Figure 34. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2019-2030)
 Figure 35. Global Recombinant Coagulation Factor Concentrate Price by Application (2019-2030) & (US$/Unit)
 Figure 36. China Recombinant Coagulation Factor Concentrate Market Share by Application in 2023 & 2030
 Figure 37. China Recombinant Coagulation Factor Concentrate Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 38. China Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Application (2019-2030)
 Figure 39. China Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030) & (K Units)
 Figure 40. China Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2019-2030)
 Figure 41. China Recombinant Coagulation Factor Concentrate Price by Application (2019-2030) & (US$/Unit)
 Figure 42. The Top 5 and 10 Largest Manufacturers of Recombinant Coagulation Factor Concentrate in the World: Market Share by Recombinant Coagulation Factor Concentrate Revenue in 2023
 Figure 43. Global Recombinant Coagulation Factor Concentrate Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 44. Global Recombinant Coagulation Factor Concentrate Sales in Volume Market Share by Region (2019-2030)
 Figure 45. Global Recombinant Coagulation Factor Concentrate Sales in Value Market Share by Region (2019-2030)
 Figure 46. Americas Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 47. Americas Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 48. Americas Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030) & (K Units)
 Figure 49. Americas Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2019-2030)
 Figure 50. Americas Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030) & (K Units)
 Figure 51. Americas Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2019-2030)
 Figure 52. United States Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Canada Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Mexico Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Brazil Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 56. EMEA Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 57. EMEA Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 58. EMEA Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030) & (K Units)
 Figure 59. EMEA Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2019-2030)
 Figure 60. EMEA Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030) & (K Units)
 Figure 61. EMEA Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2019-2030)
 Figure 62. Europe Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 63. Middle East Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 64. Africa Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 65. China Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 66. China Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 67. China Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030) & (K Units)
 Figure 68. China Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2019-2030)
 Figure 69. China Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030) & (K Units)
 Figure 70. China Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2019-2030)
 Figure 71. APAC Recombinant Coagulation Factor Concentrate Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 72. APAC Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 73. APAC Recombinant Coagulation Factor Concentrate Sales by Type (2019-2030) & (K Units)
 Figure 74. APAC Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2019-2030)
 Figure 75. APAC Recombinant Coagulation Factor Concentrate Sales by Application (2019-2030) & (K Units)
 Figure 76. APAC Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2019-2030)
 Figure 77. Japan Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 78. South Korea Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 79. China Taiwan Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 80. Southeast Asia Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 81. India Recombinant Coagulation Factor Concentrate Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 82. Recombinant Coagulation Factor Concentrate Value Chain
 Figure 83. Recombinant Coagulation Factor Concentrate Production Process
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed

Description

The global Recombinant Coagulation Factor Concentrate revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).

In China the Recombinant Coagulation Factor Concentrate revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and China Recombinant Coagulation Factor Concentrate market, also covers the segmentation data of other regions in regional level and county level.

Market Segmentation